Dr. Morris and future Distinguished Scholars will create and manage an original educational project to disseminate new knowledge about thrombosis and advance the creation of best practices in patient care. Specifically, Dr. Morris will explore pulmonary care in his project "Learning From Ourselves: Application of the Continuous Quality Improvement Model for Management of Pulmonary Embolism." He will receive an annual stipend over a three-year period and then serve as a mentor for the next Distinguished Scholar.
"The Distinguished Scholar presents an opportunity to make an outstanding contribution to the diagnosis and treatment of thrombosis," said Diane E. Stover, MD, FCCP, President of The CHEST Foundation. "By taking a unique approach, the scholar can explore and promote alternatives for the treatment of thrombosis that will ultimately benefit many patients."
Traditionally, funding is available for scholars to do clinical research or basic science. The Distinguished Scholar award will instead support activities such as the development of public policy, patient education models, or economic analysis of treatment or care delivery in this patient group. Organon Sanofi~Synthelabo's investment in the Distinguished Scholar program reflects the importance of promoting new knowledge about thrombosis that will translate into improvement in clinical practice and saving liv
Contact: Jennifer Stawarz
American College of Chest Physicians